Quantcast

Latest Anti-diabetic drug Stories

2009-06-06 10:00:00

RIDGEFIELD, Conn., June 6 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced its pipeline of oral antidiabetic compounds, establishing itself in the type 2 diabetes therapeutic area. The Company is investigating compounds in Phase II and Phase III clinical development worldwide. New Phase II data results for linagliptin (BI 1356), a dipeptidyl peptidase 4 (DPP-4) inhibitor and the Company's lead diabetes compound, were presented today at the 69th Annual American...

2009-06-06 10:00:00

Two-year study presented at the American Diabetes Association's 69th Scientific Sessions shows investigational product comparable to standard insulin therapy in pulmonary function tests NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder is a well-tolerated, ultra rapid acting insulin with changes in pulmonary function tests comparable to usual antidiabetic treatment, according to data presented today at the American Diabetes Association's...

2009-06-05 07:00:00

Today's announcement hurts thousands of Avandia patients, counsel says HOUSTON, June 5 /PRNewswire/ -- Noted Houston trial lawyer Mark Lanier of The Lanier Law Firm says "useless trick science" is the basis for a new study being unveiled today in New Orleans by drug maker GlaxoSmithKline (NYSE: GSK) about the side effects caused by the company's diabetes medication Avandia, which reportedly has been linked to heart problems in thousands of patients. Mr. Lanier represents many former Avandia...

2009-05-14 08:30:00

Results show improved insulin sensitivity and lower glucose levels without the side effects of current therapies KALAMAZOO, Mich., May 14 /PRNewswire/ -- Metabolic Solutions Development Company (MSDC) announced today that its lead compound, MSDC-0160, can improve insulin sensitivity and lower blood glucose levels in humans without the side effects of current therapies when taken over a 28-day period, according to preliminary data derived from the company's Phase IIa clinical trial. "This...

2009-05-08 08:14:00

Approximately 60 Percent of Patients Reached American Diabetes Association's Recommended Average Blood Sugar Level PRINCETON, N.J., May 8 /PRNewswire/ -- Novo Nordisk today announced results from the TITRATE(R) study showing that Levemir(R) (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar. Type 2 diabetes patients took a more active role in their treatment by adjusting their own dosing, after being trained and given an adjustment schedule...

2009-04-21 07:30:00

- Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities - BRIDGEWATER, N.J., April 21 /PRNewswire-FirstCall/ -- Tony Award-winning actor and Broadway star Ben Vereen will reprise his role as a diabetes advocate and again Take the Stage for Diabetes Awareness with sanofi-aventis U.S. to share his personal experience with diabetes. This spring Mr. Vereen will extend the national campaign he kicked off in September of 2008 by traveling to six additional cities...

2009-04-21 07:30:00

Ben Vereen to Extend National Diabetes Awareness Campaign in Six Additional Cities BRIDGEWATER, N.J., April 21 /PRNewswire/ -- Tony Award-winning actor and Broadway star Ben Vereen will reprise his role as a diabetes advocate and again Take the Stage for Diabetes Awareness with sanofi-aventis U.S. to share his personal experience with diabetes. This spring Mr. Vereen will extend the national campaign he kicked off in September of 2008 by traveling to six additional cities across the country....

2009-04-15 07:34:00

Researchers at the University of Toronto and St. Michael's Hospital Present New Findings on Nuts and Diabetes at Experimental Biology Conference in New Orleans, LA DAVIS, Calif., April 15 /PRNewswire/ -- While nuts have been shown to help reduce the risk of heart disease, new findings, which will be presented this week at the Experimental Biology Annual Meeting in New Orleans, LA, suggest that they may also play an important role in the management of diabetes. Researchers from the...

ab9e57c9140e2113e6b9cba5931cd5f51
2009-04-14 12:41:56

The majority of patients with type 1 diabetes who underwent a certain type of stem cell transplantation became insulin free, several for more than three years, with good glycemic control, and also increased C-peptide levels, an indirect measure of beta-cell function, according to a study in the April 15 issue of JAMA, a theme issue on diabetes. Richard K. Burt, M.D., of the Northwestern University Feinberg School of Medicine, Chicago, presented the findings of the study at a JAMA media...

2009-03-03 08:33:21

Study reports results from first 8 countriesA major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient satisfaction.The findings, reported in the March issue of IJCP, the International Journal of Clinical Practice, show that 53 per cent achieved a blood glucose (HbA1c) level of less than seven per cent, the target set by the International Diabetes...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related